Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
Would you recommend routinely checking ANCA levels just prior to a planned kidney transplantation in patients with a history of ESKD secondary to ANCA-associated vasculitis?
Related Questions
Do you taper steroids more aggressively to decrease the risk of developing new-onset diabetes after transplantation in kidney transplant recipients who had pretransplant impaired fasting glucose?
Do you have specific waiting periods before a patient can be listed for a kidney transplant if they have a past history of malignancy?
What is your approach to managing a kidney transplant patient who develops BK viremia after treatment for rejection?
How much proteinuria would warrant consideration of native kidney nephrectomies at the time of a kidney transplant?
How do you approach chronic T cell mediated rejection when patient is intolerant to steroids?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
What is your approach for patients with a history of nephrolithiasis who are being evaluated for living kidney donation?
When do you recommend genetic testing prior to kidney transplantation for a patient with ESKD secondary to FSGS?
How do you approach chronic active AMR concurrent with changes of CNI toxicity?
When do you use ambulatory blood pressure monitoring to assess hypertension in a living kidney donor candidate?
